Skip to main content
Fig. 4 | BMC Palliative Care

Fig. 4

From: Management challenges of invasive breast carcinoma in a male patient who refused treatment: a case report

Fig. 4

Hormonal receptor status determination indicating a strong immunostaining of tumor cells for estrogen receptors, IHC staining at 100 x original magnification (A); a moderate immunostaining of nearly all cells for progesterone (PR) receptors, IHC at 40 x original magnification (B), and negative immunoexpression of all tumour cells by HER-2, IHC at 40 x original magnification (C)

Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us